Schott adds to melting capacity for pharma glass in India

Long-term glass supply to the Indian pharma industry

Schott adds to melting capacity for pharma glass in India
Groundbreaking at Jambusar, Gujarat

Schott, a global leader in pharmaceutical glass manufacturing, is investing a total of 70 million Euros (approximately Indian Rs 600 crore) in the expansion of its Indian tubing site in Jambusar, Gujarat, following several million investments in the last few years. 

“Against the backdrop of the growth trend in the Indian pharmaceutical business and the pandemic, we want to commit to secure the supply of pharma glass,” explains Patrick Markschläger, executive vice president of Schott’s Business Unit Tubing. 

“The increase of over 30 percent in the facility’s overall Indian production capacity is at the same time a commitment to supporting the government’s vision of India becoming a global pharmaceutical hub,” adds Pawan Shukla, managing director Schott Glass India, during the groundbreaking event at the site. 

The additional tank is scheduled to operate at the beginning of 2023, with the second one following a year later. The expansion in Jambusar will create new jobs for around 225 employees and is part of the company’s more than US$ 1 billion strategic investment program through 2025, leveraging the global pharma tubing and packaging business. 

Schott fiolax glass usage in vaccine packaging

Schott has been a frontrunner in the fight against Covid-19 and provided pharmaceutical glass for primary packaging to fill billions of Covid-19 vaccines worldwide. In India, almost all approved vaccines are packed in Fiolax glass made by Schott. With additional melting tanks and production lines, the company intends to ensure that this Asian manufacturing hub can adequately supply high-quality pharma glass for the Indian pharma industry and neighboring countries.

The increase of melting capacities in India, supplemented by a batch house, a driveway, and a canteen for the employees, is part of Schott’s commitment to invest over Euro 100 million (Indian Rupees 840 crore) in its Indian tubing facilities and triple production capacity to produce Fiolax glass tubing for domestic and export demands.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now


Please enter your comment!
Please enter your name here